Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 3OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 4Breast Neoplasms 4Sarcoma 3Rhabdomyosarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Teratoma 1Sarcoma, Synovial 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Pancreatic Neoplasms 1Neutropenia 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Leiomyosarcoma 1Kidney Neoplasms 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Paclitaxel 3Docetaxel 3Watchful Waiting 2Tamoxifen 2Immunohistochemistry 2Goserelin 2Everolimus 2Cyclophosphamide 2Bevacizumab 2Anastrozole 2vandetanib 1pegfilgrastim 1lonafarnib 1exemestane 1Trastuzumab 1Sunitinib 1Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Metformin 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Lapatinib 1High-Energy Shock Waves 1Gene Expression Profiling 1Doxorubicin 1Dasatinib 1Chemotherapy, Adjuvant 1Biopsy, Needle 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms, Male × pegfilgrastim × Clear all
NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

SWOG Cancer Research Network

Phase 3 Active not recruiting
3,294 enrolled 22 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡